par  Wens, Robert  ;Taminne, M;Devriendt, Jacques
;Taminne, M;Devriendt, Jacques  ;Collart, Frédéric
;Collart, Frédéric  ;Broeders, Emine Nilufer
;Broeders, Emine Nilufer  ;Mestrez, Fernand
;Mestrez, Fernand  ;Germanos, H.;Dratwa, Max
;Germanos, H.;Dratwa, Max 
Référence Peritoneal dialysis international, 18, 6, page (603-609)
Publication Publié, 1998
           ;Taminne, M;Devriendt, Jacques
;Taminne, M;Devriendt, Jacques  ;Collart, Frédéric
;Collart, Frédéric  ;Broeders, Emine Nilufer
;Broeders, Emine Nilufer  ;Mestrez, Fernand
;Mestrez, Fernand  ;Germanos, H.;Dratwa, Max
;Germanos, H.;Dratwa, Max 
Référence Peritoneal dialysis international, 18, 6, page (603-609)
Publication Publié, 1998
                                                                                                       
			Article révisé par les pairs
                                                  
        | Résumé : | Serious discrepancies between glycemia measurements obtained with an Accutrend Sensor (Boehringer Mannheim GmbH, Mannheim, Germany) type analyzer (based on a glucose dehydrogenase enzymatic reaction) and measurements obtained in the laboratory by a reference method (hexokinase) have been found in an insulin-requiring, diabetic, continuous ambulatory peritoneal dialysis (CAPD) patient treated with icodextrin 7.5% (Extraneal; Baxter Healthcare SA, Castlebar, Ireland), a new osmotic agent for peritoneal dialysis. We therefore investigated the respective role of the Analyzer and of the glucose polymer in this hitherto undescribed problem. | 



